Example: confusion, disorientation, attention, memory, and language deficits
Diagnostic Criteria for Delirium:
A. Disturbance in attention and awareness.
B. Disturbance develops over a short period and tends to fluctuate in severity.
C. Additional disturbance in cognition (e.g., memory deficit, disorientation, language, visuospatial ability, or perception).
D. The disturbances are not better explained by another neurocognitive disorder and do not occur in the context of a severely reduced level of arousal.
E. Evidence from history, physical examination, or lab findings that the disturbance is a direct physiological consequence of another medical condition, substance intoxication or withdrawal, exposure to a toxin, or multiple etiologies.
Statistics:
20% of older adults in acute care (ER)
Highest prevalence:
Older adults
AIDS patients
Cancer patients
Medical patients
Full recovery = several weeks
*Vital signs to be checked
Subtypes of delirium:
Delirium due to a general medical condition
Substance-induced delirium
Delirium due to multiple etiologies
Delirium not otherwise specified
Causes:
Drug intoxication
Medications
Illicit drugs
Ecstasy (methylene-dioxymethamphetamine)
Poisons
Withdrawal from drugs
Infections
Head injury
High fever
50% of people with dementia suffer at least one episode of delirium
Age
Infections
Head injury/brain trauma
Sleep deprivation
Immobility
Excessive stress
fMRI scanning - Ethical concerns
Treatment:
Treat underlying medical or withdrawal problems.
Acute delirium:
Haloperidol or olanzapine
First line of treatment
Psychosocial interventions:
Education
Reassurance
Coping strategies
Prevention:
Proper medical care
Proper medication use
Major and Mild Neurocognitive Disorders
Major neurocognitive disorder (previously labeled dementia) is a gradual deterioration of brain functioning that affects:
Memory
Judgment
Language
Other advanced cognitive processes
Mild neurocognitive disorder is a new DSM-5 disorder that focuses attention on the early stages of cognitive decline.
Diagnostic Criteria for Mild Neurocognitive Disorder:
A. Evidence of modest cognitive decline from a previous level of performance in one or more cognitive domains.
Concern of the individual, a knowledgeable informant, or the clinician that there has been a mild decline in cognitive function; and
A modest impairment in cognitive performance, preferably documented by standardized neuropsychological testing or, in its absence, another quantified clinical assessment.
B. The cognitive deficits do not interfere with capacity for independence in everyday activities.
C. The cognitive deficits do not occur exclusively in the context of a delirium.
D. The cognitive deficits are not better explained by another mental disorder.
Specify whether due to:
Alzheimer's disease
Frontotemporal lobar degeneration
Lewy body disease
Vascular disease
Traumatic brain injury
Substance/medication use
HIV infection
Prion disease
Parkinson's disease
Huntington's disease
Another medical condition
Multiple etiologies
Unspecified
Clinical description:
Gradual deterioration of brain functioning
Affects multiple domains:
Judgment
Memory
Language
Advanced cognitive processes
Multiple etiologies
Initial symptoms:
Memory impairment
Visuospatial skills deficits
Agnosia
Facial agnosia
Delusions
Depression
Agitation
Aggression
Apathy
Later symptoms:
Continued cognitive decline
Assistance with activities of daily living
Death = inactivity + other illnesses
Pneumonia
Statistics:
Onset:
Any age
Most common in the elderly
Prevalence:
New case every seven seconds
5% older than 65
20-40% over age 85
Rates double with every 5 years after age 75
Alzheimer’s in centenarians = 100%
Longer lifespan
Mild neurocognitive disorder
10% over 70
Black men and women at higher risk
Cost of caring for 1 year 100 billion
DSM-5 Classes of Neurocognitive Disorder
Etiology
Dementia of the Alzheimer’s type
Vascular injury
Frontotemporal degeneration
Traumatic brain injury
Lewy body disease
Parkinson’s disease
HIV infection
Substance use
Huntington’s disease
Prion disease
Another medical condition
Neurocognitive Disorder Due to Alzheimer’s Disease
Clinical description
Multiple cognitive deficits
Memory
Orientation
Judgment
Reasoning
Develop gradually and steadily
Confusion
Agitation / combativeness
Depression
Anxious
Sundowner syndrome
Range of cognitive deficits
Aphasia
Apraxia
Agnosia
Executive function
Significant social and occupational impairments
Definitive diagnosis = Autopsy
Brain scans
Spinal fluid
Mental status exam
Testing for Neurocognitive Disorder due to Alzheimer's Disease
The examination also includes an assessment of the patient's level of consciousness: alert, drowsy, stupor, or coma.
Note: One part of the diagnosis of the neurocognitive disorder due to Alzheimer's disease uses a relatively simple test of the patient's mental state and abilities, like this one, called the Mini Mental State Inpatient Consultation Form. A low score on such a test does not necessarily indicate a medical diagnosis of the disorder.
Statistics
Nature and progression of the disease
“Nun study”
Deterioration
Early and later stages = slow
During middle stages = rapid
Post-diagnosis survival = 8 years
Onset = 60s or 70s
Early onset = 40s to 50s
50% of the cases of neurocognitive disorder are found to be the result of Alzheimer’s disease
Prevalence
5 million Americans, several million worldwide
Higher :
Poorly educated
Women
Estrogen?
Lower:
Higher education
Cognitive reserve theory
American Indians - lower
Diagnostic Criteria for Major or Mild Neurocognitive Disorder due to Alzheimer's Disease
A. The criteria are met for major or mild neurocognitive disorder.
B. There is insidious onset and gradual progression of impairment in one or more cognitive domains (for major neurocognitive disorder, two domains must be impaired).
C. Criteria are met for either probable or possible Alzheimer's disease as follows:
For major neurocognitive disorder:
Probable Alzheimer's disease is diagnosed if either of the following is present; otherwise, possible Alzheimer's disease should be diagnosed.
1. Evidence of a causative Alzheimer's disease genetic mutation from family history or genetic testing
2. All three of the following are present:
a. Clear evidence of decline in memory and learning and at least one other cognitive domain (based on detailed history or serial neuropsychological testing).
b. Steadily progressive, gradual decline in cognition, without extended plateaus.
c. No evidence of mixed etiology (i.e., absence of other neurodegenerative or cerebrovascular disease, or another neurological, mental, or systemic disease or condition likely contributing to cognitive decline).
For mild neurocognitive disorder:
Probable Alzheimer's disease is diagnosed if there is evidence of a causative Alzheimer's disease genetic mutation from either genetic testing or family history.
Possible Alzheimer's disease is diagnosed if there is no evidence of a causative Alzheimer's disease genetic mutation from either genetic testing or family history, and all three of the following are present:
1. Clear evidence of decline in memory and learning.
2. Steadily progressive, gradual decline in cognition, without extended plateaus.
3. No evidence of mixed etiology (i.e., absence of other neurodegenerative or cerebrovascular disease, or another neurological or systemic disease or condition likely contributing to cognitive decline).
D. The disturbance is not better explained by cerebrovascular disease, another neurodegenerative disease, the effects of a substance, or another mental, neurological, or systemic disorder.
Vascular Neurocognitive Disorder
Vascular neurocognitive disorder is a progressive brain disorder that is a common cause of neurocognitive deficits
Clinical description
Progressive brain disorder
Blockage or damage to blood vessels
Onset is often sudden
Stroke
Variable impairments
DSM-5 Criteria
Cognitive disturbances
Speed of information processing and executive functioning
Greater motor problems
Weakness in limbs
Significant impairments
Diagnostic Criteria for Major or Mild Vascular Neurocognitive Disorder
A. The criteria are met for major or mild neurocognitive disorder.
B. The clinical features are consistent with a vascular etiology as suggested by either of the following:
1. Onset of the cognitive deficits is temporally related to one or more cerebrovascular events.
2. Evidence for decline is prominent in complex attention (including processing speed) and frontal-executive function.
C. There is evidence of the presence of cerebrovascular disease from history, physical examination, and/or neuroimaging considered sufficient to account for the neurocognitive deficits.
D. The symptoms are not better explained by another brain disease or systemic disorder.
Probable vascular neurocognitive disorder is diagnosed if one of the following is present, otherwise, possible vascular neurocognitive disorder should be diagnosed:
1. Clinical criteria are supported by neuroimaging evidence of significant parenchymal injury attributed to cerebrovascular disease (neuroimaging-supported).
2. The neurocognitive syndrome is temporally related to one or more documented cerebrovascular events.
3. Both clinical and genetic (e.g., cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy) evidence of cerebrovascular disease is present.
Possible vascular neurocognitive disorder is diagnosed if the clinical criteria are met but neuroimaging is not available and the temporal relationship of the neurocognitive syndrome with one or more cerebrovascular events is not established.
Prevalence
1.5% in age 70 to 75
15% in age 80 or older
Men>Women
Higher rates of cardiovascular disease
Most will require formal nursing care
Death from infection
Pneumonia
Weak immune system
Other Medical Conditions That Cause Neurocognitive Disorder
Frontotemporal degeneration
Traumatic brain injury
Lewy body disease
Parkinson’s disease
HIV infection
Substance use
Huntington’s disease
Prion disease
Normal pressure hydrocephalus (excessive water in the cranium, resulting from brain shrinkage)
Hypothyroidism (an underactive thyroid gland)
Brain Tumor
Vitamin B12 deficiency
Head trauma
Accidents are most common cause
Memory loss is primary symptom
Chronic Traumatic Encephalopathy (CTE)
Frontotemporal Neurocognitive Disorder
Damage the frontal or temporal regions of the brain affecting
Personality
Language
Behavior
Two types
Declines in appropriate behavior
Declines language
Diagnostic Criteria for Major or Mild Frontotemporal Neurocognitive Disorder
A. The criteria are met for major or mild neurocognitive disorder.
B. The disturbance has insidious onset and gradual progression.
C. Either (1) or (2):
1. Behavioral variant:
a. Three or more of the following behavioral symptoms:
i. Behavioral disinhibition.
ii. Apathy or inertia.
iii. Loss of sympathy or empathy.
iv. Perseverative, stereotyped, or compulsive/ritualistic behavior.
v. Hyperorality and dietary changes.
b. Prominent decline in social cognition and/or executive abilities.
2. Language variant:
a. Prominent decline in language ability, in the form of speech production, word finding, object naming, grammar, or word comprehension.
D. Relative sparing of learning and memory and perceptual-motor function.
E. The disturbance is not better explained by cerebrovascular disease, another neurodegenerative disease, the effects of a substance, or another mental, neurological, or systemic disorder.
Probable frontotemporal neurocognitive disorder is diagnosed if either of the following is present; otherwise, possible frontotemporal neurocognitive disorder should be diagnosed:
1. Evidence of a causative frontotemporal neurocognitive disorder genetic mutation, from either family history or genetic testing.
2. Evidence of disproportionate frontal and/or temporal lobe involvement from neuroimaging.
Possible frontotemporal neurocognitive disorder is diagnosed if there is no evidence of a genetic mutation, and neuroimaging has not been performed.
Pick’s Disease
Rare neurological condition
5% of all dementias
Cortical impairment pattern
Early onset = 40s or 50s
Traumatic Brain Injury
Neurocognitive disorder due to traumatic brain injury - includes symptoms that persist for at least a week following the trauma, including executive dysfunction
Diagnostic Criteria for Major or Mild Neurocognitive Disorder due to Traumatic Brain Injury
A. The criteria are met for major or mild neurocognitive disorder.
B. There is evidence of a traumatic brain injury-that is, an impact to the head or other mechanisms of rapid movement or displacement of the brain within the skull, with one or more of the following:
1. Loss of consciousness.
2. Posttraumatic amnesia.
3. Disorientation and confusion.
4. Neurological signs (e.g., neuroimaging demonstrating injury; a new onset of seizures; a marked worsening of a preexisting seizure disorder; visual field cuts; anosmia; hemiparesis).
C. The neurocognitive disorder presents immediately after the occurrence of the traumatic brain injury or immediately after recovery of consciousness and persists past the acute post-injury period.
Lewy Body
Neurocognitive disorder due to Lewy body disease
Lewy bodies are microscopic deposits of a protein that damage brain cells over time
Diagnostic Criteria for Major or Mild Neurocognitive Disorder with Lewy Bodies
A. The criteria are met for major or mild neurocognitive disorder.
B. The disorder has an insidious onset and gradual progression.
C. The disorder meets a combination of core diagnostic features and suggestive diagnostic features for either probable or possible neurocognitive disorder with Lewy Bodies.
For probable major or mild neurocognitive disorder with Lewy Bodies, the individual has two core features, or one suggestive feature with one or more core features.
For possible major or mild neurocognitive disorder with Lewy Bodies, the individual has only one core feature, or one or more suggestive features.
1. Core diagnostic features:
a. Fluctuating cognition with pronounced variations in attention and alertness.
b. Recurrent visual hallucinations that are well formed and detailed.
c. Spontaneous features of parkinsonism, with onset subsequent to the development of cognitive decline.
2. Suggestive diagnostic features:
a. Meets criteria for rapid eye movement sleep behavior disorder.
b. Severe neuroleptic sensitivity.
D. The disturbance is not better explained by cerebrovascular disease, another neurodegenerative disease, the effects of a substance, or another mental, neurological, or systemic disorder.
Parkinson’s Disease
Degenerative brain disorder
Dopamine pathway damage
1 out of 1,000 people worldwide
Motor problems
Tremors
Posture
Walking
Speech
Sub-cortical impairment pattern
Not all with PD will develop dementia
Diagnostic Criteria for Neurocognitive Disorder due to Parkinson's Disease
A. The criteria are met for major or mild neurocognitive disorder.
B. The disturbance occurs in the setting of established Parkinson's disease.
C. There is insidious onset and gradual progression of impairment.
D. The neurocognitive disorder is not attributable to another medical condition and is not better explained by another mental disorder.
Major or mild neurocognitive disorder probably due to Parkinson's disease should be diagnosed if 1 and 2 are both met. Major or mild neurocognitive disorder possibly due to Parkinson's disease should be diagnosed if 1 or 2 is met:
1. There is no evidence of mixed etiology (i.e., absence of other neurodegenerative or cerebrovascular disease or another neurological, mental, or systemic disease or condition likely contributing to cognitive decline).
2. The Parkinson's disease clearly precedes the onset of neurocognitive disorder.
Human Immunodeficiency Virus-Type 1 (HIV-1)
Clinical description
HIV causes neurological impairments and dementia
Cognitive slowness
Impaired attention
Forgetfulness
Clumsiness
Repetitive movements
Tremors/leg weakness
Apathy
Social withdrawal
Clinical description
Later stages of HIV infection
Fewer with HAART medications
10% patients now experience neurocognitive disorder
Sub-cortical dementia
Motor skill impairments
Slowing
Anxiety
Depression
No aphasia
Diagnostic Criteria for Major or Mild Neurocognitive Disorder due to HIV Infection
A. The criteria are met for major or mild neurocognitive disorder.
B. There is documented infection with human immunodeficiency virus (HIV).
C. The Neurocognitive Disorder is not better explained by non-HIV conditions, including secondary brain diseases. such as progressive multifocal leukoencephalopathy or cryptococcal meningitis.
D. The neurocognitive disorder is not attributable to another medical condition and is not better explained by a mental disorder.
Huntington’s Disease
Genetic autosomal dominant disorder
Chromosome 4
Early onset = 40s or 50s
Motor symptoms
Chorea
Sub-cortical dementia pattern
Diagnostic Criteria for Major or Mild Neurocognitive Disorder due to Huntington's Disease
A. The criteria are met for major or mild neurocognitive disorder.
B. There is insidious onset and gradual progression.
C. There is clinically established Huntington's disease, or risk for Huntington's disease based on family history or genetic testing.
D. The neurocognitive disorder is not attributable to another medical condition and is not better explained by another mental disorder.
Prion Disease
Always fatal
Not contagious in humans
Cannibalism
Blood transfusions
Linked to mad cow disease
Diagnostic Criteria for Neurocognitive Disorder due to Prion Disease
A. The criteria are met for major or mild neurocognitive disorder.
B. There is insidious onset, and rapid progression of impairment is common.
C. There are motor features of prion disease, such as myoclonus or ataxia, or biomarker evidence.
D. The neurocognitive disorder is not attributable to another medical condition and is not better explained by another mental disorder.
Creutzfeldt-Jakob Disease
Type of Prion disease
1 in 1,000,000
Linked to mad cow disease
10 new cases of variant Creutzfeldt-Jakob Disease - United Kingdom
Symptoms similar to other neurocognitive disorders
Aphasia
Apraxia
Agnosia
Executive function impairments
Diagnostic Criteria for Substance/Medication-Induced Major or Mild Neurocognitive Disorder
A. The criteria are met for major or mild neurocognitive disorder.
B. The neurocognitive impairments do not occur exclusively during the course of a delirium and persist beyond the usual duration of intoxication and acute withdrawal.
C. The involved substance or medication and duration and extent of use are capable of producing the neurocognitive impairment.
D. The temporal course of the neurocognitive deficits is consistent with the timing of substance or medication use and abstinence (e.g., the deficits remain stable or improve after a period of abstinence).
E. The neurocognitive disorder is not attributable to another medical condition and is not better explained by another mental disorder.
Causes of Neurocognitive Disorder
Early, unsupported views
Smoking
Alzheimer’s disease the most common cause of neurocognitive disorder
Neurobiological influences
Neurofibrillary tangles
Tau
Amyloid plaques
Neuritic or senile plaques
Spinal fluid
β-amyloid peptides
Cortical atrophy
Genetic influences
Polygenetic
Chromosomes 21, 19, 14, 12, 1
Chromosome 14—early onset
Chromosome 19—late onset
Deterministic genes
Preseniln-1, Preseniln-2
β-amyloid precursor protein
APP gene on chromosome 21
APP produces amyloid in plaques
Down syndrome and Alzheimer incidence
Two mechanisms that may account for amyloid protein buildup
Amyloid precursor protein (APP)
Chromosome 21
Apolipoprotein E (apo E)
Susceptibility genes
apoE2
apoE3
apoE4
Chromosome 19
Late-onset Alzheimer’s
Higher prevalence in families with Alzheimer’s
Interaction with head injuries
Diagnostic Criteria for Substance/Medication-Induced Major or Mild Neurocognitive Disorder
A. The criteria are met for major or mild neurocognitive disorder.
B. The neurocognitive impairments do not occur exclusively during the course of a delirium and persist beyond the usual duration of intoxication and acute withdrawal.
C. The involved substance or medication and duration and extent of use are capable of producing the neurocognitive impairment.
D. The temporal course of the neurocognitive deficits is consistent with the timing of substance or medication use and abstinence (e.g., the deficits remain stable or improve after a period of abstinence).
E. The neurocognitive disorder is not attributable to another medical condition and is not better explained by another mental disorder.